Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J C Ballenger

Showing results (81-90 of 193) with videos related to

Pageof 20
Sort By:
Archives of General Psychiatry|January 1, 1993
Eating disorders and social phobiaT D Brewerton, R B Lydiard, J C Ballenger, et al.
The American Journal of Psychiatry|January 20, 1998
Double-blind, fixed-dose, placebo-controlled study of paroxetine in the treatment of panic disorderJ C Ballenger, D E Wheadon, M Steiner, et al.
Archives of General Psychiatry|December 1, 1981
Depressed patients have decreased binding of tritiated imipramine to platelet serotonin "transporter"S M Paul, M Rehavi, P Skolnick, et al.
Psychopharmacology Bulletin|January 1, 1983
Cerebrospinal fluid somatostatin in primary affective disorderD R Rubinow, P W Gold, R M Post, et al.
Epilepsia|March 1, 1986
Neuroendocrine effects of carbamazepine in patients with affective illnessR T Joffe, R M Post, J C Ballenger, et al.
Archives of General Psychiatry|April 1, 1986
Dopaminergic effects of carbamazepine. Relationship to clinical response in affective illnessR M Post, D R Rubinow, T W Uhde, et al.
Psychopharmacology|January 1, 1985
Effects of carbamazepine on cerebrospinal fluid somatostatinD R Rubinow, R M Post, P W Gold, et al.
Psychiatric Services (Washington, D.C.)|May 29, 2001
A brief scale for assessing patients' satisfaction with care in outpatient psychiatric servicesK L Pellegrin, G W Stuart, B Maree, et al.
Lancet (London, England)|November 10, 1979
Effects of 1-desamo-8-D-arginine vasopressin on behaviour and cognition in primary affective disorderP W Gold, H Weingartner, J C Ballenger, et al.
The American Journal of Psychiatry|September 1, 1990
Cocaine abuse among schizophrenic patientsK Brady, R Anton, J C Ballenger, et al.
Pageof 20

Showing results (81-90 of 193) with videos related to

Sort By:
Pageof 20
Archives of General Psychiatry|January 1, 1993
Eating disorders and social phobiaT D Brewerton, R B Lydiard, J C Ballenger, et al.
The American Journal of Psychiatry|January 20, 1998
Double-blind, fixed-dose, placebo-controlled study of paroxetine in the treatment of panic disorderJ C Ballenger, D E Wheadon, M Steiner, et al.
Archives of General Psychiatry|December 1, 1981
Depressed patients have decreased binding of tritiated imipramine to platelet serotonin "transporter"S M Paul, M Rehavi, P Skolnick, et al.
Psychopharmacology Bulletin|January 1, 1983
Cerebrospinal fluid somatostatin in primary affective disorderD R Rubinow, P W Gold, R M Post, et al.
Epilepsia|March 1, 1986
Neuroendocrine effects of carbamazepine in patients with affective illnessR T Joffe, R M Post, J C Ballenger, et al.
Archives of General Psychiatry|April 1, 1986
Dopaminergic effects of carbamazepine. Relationship to clinical response in affective illnessR M Post, D R Rubinow, T W Uhde, et al.
Psychopharmacology|January 1, 1985
Effects of carbamazepine on cerebrospinal fluid somatostatinD R Rubinow, R M Post, P W Gold, et al.
Psychiatric Services (Washington, D.C.)|May 29, 2001
A brief scale for assessing patients' satisfaction with care in outpatient psychiatric servicesK L Pellegrin, G W Stuart, B Maree, et al.
Lancet (London, England)|November 10, 1979
Effects of 1-desamo-8-D-arginine vasopressin on behaviour and cognition in primary affective disorderP W Gold, H Weingartner, J C Ballenger, et al.
The American Journal of Psychiatry|September 1, 1990
Cocaine abuse among schizophrenic patientsK Brady, R Anton, J C Ballenger, et al.
Pageof 20